array:24 [
  "pii" => "S2666275221002629"
  "issn" => "26662752"
  "doi" => "10.1016/j.abdp.2021.11.006"
  "estado" => "S300"
  "fechaPublicacion" => "2022-01-01"
  "aid" => "465"
  "copyright" => "Sociedade Brasileira de Dermatologia"
  "copyrightAnyo" => "2021"
  "documento" => "simple-article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by/4.0/"
  "subdocumento" => "crp"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "en" => array:19 [
      "pii" => "S0365059621002579"
      "issn" => "03650596"
      "doi" => "10.1016/j.abd.2020.08.032"
      "estado" => "S300"
      "fechaPublicacion" => "2022-01-01"
      "aid" => "465"
      "copyright" => "Sociedade Brasileira de Dermatologia"
      "documento" => "simple-article"
      "crossmark" => 1
      "licencia" => "http://creativecommons.org/licenses/by/4.0/"
      "subdocumento" => "crp"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:1 [
        "total" => 0
      ]
      "en" => array:12 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Case Report</span>"
        "titulo" => "Chronic recalcitrant erythema nodosum leprosum&#58; therapeutic dilemma and role of <span class="elsevierStyleItalic">mycobacterium indicus pranii</span> vaccine"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "tieneResumen" => "en"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "49"
            "paginaFinal" => "53"
          ]
        ]
        "contieneResumen" => array:1 [
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:8 [
            "identificador" => "fig0005"
            "etiqueta" => "Figure 1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr1.jpeg"
                "Alto" => 1546
                "Ancho" => 2174
                "Tamanyo" => 487304
              ]
            ]
            "detalles" => array:1 [
              0 => array:3 [
                "identificador" => "at0005"
                "detalle" => "Figure "
                "rol" => "short"
              ]
            ]
            "descripcion" => array:1 [
              "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Lepromatous Leprosy with ENL showing lesions before vaccination&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Sunil Kumar Gupta, Sushantika Kumari"
            "autores" => array:2 [
              0 => array:2 [
                "nombre" => "Sunil Kumar"
                "apellidos" => "Gupta"
              ]
              1 => array:2 [
                "nombre" => "Sushantika"
                "apellidos" => "Kumari"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "pt" => array:9 [
          "pii" => "S2666275221002629"
          "doi" => "10.1016/j.abdp.2021.11.006"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "pt"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275221002629?idApp=UINPBA00008Z"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059621002579?idApp=UINPBA00008Z"
      "url" => "/03650596/0000009700000001/v1_202201230559/S0365059621002579/v1_202201230559/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S2666275221002654"
    "issn" => "26662752"
    "doi" => "10.1016/j.abdp.2021.11.009"
    "estado" => "S300"
    "fechaPublicacion" => "2022-01-01"
    "aid" => "468"
    "copyright" => "Sociedade Brasileira de Dermatologia"
    "documento" => "simple-article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by/4.0/"
    "subdocumento" => "crp"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "pt" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Caso Cl&#237;nico</span>"
      "titulo" => "Fen&#244;meno de L&#250;cio&#58; import&#226;ncia da aten&#231;&#227;o b&#225;sica e dermatol&#243;gica"
      "tienePdf" => "pt"
      "tieneTextoCompleto" => "pt"
      "tieneResumen" => "pt"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "54"
          "paginaFinal" => "57"
        ]
      ]
      "contieneResumen" => array:1 [
        "pt" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "pt" => true
      ]
      "contienePdf" => array:1 [
        "pt" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0010"
          "etiqueta" => "Figura 2"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr2.jpeg"
              "Alto" => 652
              "Ancho" => 900
              "Tamanyo" => 158290
            ]
          ]
          "descripcion" => array:1 [
            "pt" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Necrose no abdome&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Juliana Viana Pinheiro, Maria Araci de Andrade Pontes, Jos&#233; Urbano de Medeiros Neto, Heitor de S&#225; Gon&#231;alves"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Juliana Viana"
              "apellidos" => "Pinheiro"
            ]
            1 => array:2 [
              "nombre" => "Maria Araci de Andrade"
              "apellidos" => "Pontes"
            ]
            2 => array:2 [
              "nombre" => "Jos&#233; Urbano de"
              "apellidos" => "Medeiros Neto"
            ]
            3 => array:2 [
              "nombre" => "Heitor de S&#225;"
              "apellidos" => "Gon&#231;alves"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "pt"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0365059621002610"
        "doi" => "10.1016/j.abd.2020.08.033"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059621002610?idApp=UINPBA00008Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275221002654?idApp=UINPBA00008Z"
    "url" => "/26662752/0000009700000001/v1_202202030913/S2666275221002654/v1_202202030913/pt/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S2666275221002599"
    "issn" => "26662752"
    "doi" => "10.1016/j.abdp.2021.11.003"
    "estado" => "S300"
    "fechaPublicacion" => "2022-01-01"
    "aid" => "462"
    "copyright" => "Sociedade Brasileira de Dermatologia"
    "documento" => "simple-article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by/4.0/"
    "subdocumento" => "crp"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "pt" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Caso Cl&#237;nico</span>"
      "titulo" => "Hamartoma folicular basaloide associado a mucinose folicular e inflama&#231;&#227;o"
      "tienePdf" => "pt"
      "tieneTextoCompleto" => "pt"
      "tieneResumen" => "pt"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "45"
          "paginaFinal" => "48"
        ]
      ]
      "contieneResumen" => array:1 [
        "pt" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "pt" => true
      ]
      "contienePdf" => array:1 [
        "pt" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0010"
          "etiqueta" => "Figura 2"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr2.jpeg"
              "Alto" => 507
              "Ancho" => 900
              "Tamanyo" => 59279
            ]
          ]
          "descripcion" => array:1 [
            "pt" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Les&#227;o de cor laranja&#8208;rosada com forma&#231;&#227;o de escamas&#44; especialmente perifolicular&#44; sem padr&#227;o de les&#227;o melanoc&#237;tica ou vascular&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Solange Edelman, Adriana Natalia Torres Huamani, Mar&#237;a Del Valle Centeno, Andrea Bettina Cervini"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Solange"
              "apellidos" => "Edelman"
            ]
            1 => array:2 [
              "nombre" => "Adriana Natalia"
              "apellidos" => "Torres Huamani"
            ]
            2 => array:2 [
              "nombre" => "Mar&#237;a Del Valle"
              "apellidos" => "Centeno"
            ]
            3 => array:2 [
              "nombre" => "Andrea Bettina"
              "apellidos" => "Cervini"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "pt"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0365059621002543"
        "doi" => "10.1016/j.abd.2020.10.012"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059621002543?idApp=UINPBA00008Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275221002599?idApp=UINPBA00008Z"
    "url" => "/26662752/0000009700000001/v1_202202030913/S2666275221002599/v1_202202030913/pt/main.assets"
  ]
  "pt" => array:19 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Caso Cl&#237;nico</span>"
    "titulo" => "Eritema nodoso hans&#234;nico recalcitrante cr&#244;nico&#58; dilema terap&#234;utico e papel da vacina para <span class="elsevierStyleItalic">Mycobacterium indicus pranii</span>"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "49"
        "paginaFinal" => "53"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Sunil Kumar Gupta, Sushantika Kumari"
        "autores" => array:2 [
          0 => array:4 [
            "nombre" => "Sunil Kumar"
            "apellidos" => "Gupta"
            "email" => array:1 [
              0 => "dr.sunil_30@yahoo.co.in"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "Sushantika"
            "apellidos" => "Kumari"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Departamento de Dermatologia&#44; All India Institute of Medical Sciences&#44; Gorakhpur&#44; &#205;ndia"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Autor para correspond&#234;ncia&#46;"
          ]
        ]
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figura 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1772
            "Ancho" => 2174
            "Tamanyo" => 557443
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Hansen&#237;ase virchowiana com ENH mostrando a elimina&#231;&#227;o das les&#245;es ap&#243;s a vacina MIP&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Introdu&#231;&#227;o</span><p id="par0005" class="elsevierStylePara elsevierViewall">A hansen&#237;ase &#233; uma doen&#231;a infecciosa causada por <span class="elsevierStyleItalic">Mycobacterium leprae</span>&#46; A doen&#231;a afeta os nervos perif&#233;ricos&#44; a pele&#44; a mucosa do trato respirat&#243;rio superior e os olhos&#46; O curso indolente da doen&#231;a &#233; interrompido por surtos agudos denominados rea&#231;&#245;es hans&#234;nicas &#40;rea&#231;&#227;o reversa e eritema nodoso hans&#234;nico &#91;ENH&#93;&#41;&#46; O ENH &#233; caracterizado por conjuntos de p&#225;pulas e n&#243;dulos doloridos&#44; febre alta e outros sintomas constitucionais&#46; O tratamento do ENH recalcitrante cr&#244;nico &#233; dif&#237;cil e geralmente requer agentes sist&#234;micos como corticosteroides&#44; talidomida&#44; clofazimina&#44; minociclina ou imunomoduladores&#44; sozinhos ou em combina&#231;&#227;o&#44; por muitos meses&#46;<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a> A vacina para <span class="elsevierStyleItalic">Mycobacterium indicus pranii</span> &#40;MIP&#41; demonstrou ter efeitos imunoterap&#234;uticos e imunoprofil&#225;ticos em pacientes com hansen&#237;ase multibacilar&#46;<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">2</span></a> Ela tamb&#233;m reduziu a carga bacilar&#44; melhorou as les&#245;es a n&#237;vel imuno&#8208;histol&#243;gico&#44; levou &#224; elimina&#231;&#227;o completa do granuloma e reduziu a dura&#231;&#227;o da terapia multidrogas &#40;TMD&#41; em pacientes com hansen&#237;ase&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">Essa vacina n&#227;o foi amplamente testada em pacientes com rea&#231;&#245;es hans&#234;nicas&#44; pois havia o risco de precipitar uma rea&#231;&#227;o grave ap&#243;s a vacina&#231;&#227;o&#46; Nesse caso&#44; a vacina foi testada em um paciente com ENH que era dependente de esteroides e refrat&#225;rio &#224; talidomida e outros medicamentos de segunda linha&#44; e um resultado muito satisfat&#243;rio foi verificado com uma &#250;nica dose da vacina para MIP&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Relato do caso</span><p id="par0015" class="elsevierStylePara elsevierViewall">Um homem de 55 anos procurou o ambulat&#243;rio de dermatologia com hist&#243;ria de hansen&#237;ase&#44; para a qual fazia uso de TMD havia um ano e meio&#46; Nos &#250;ltimos 8 meses&#44; o paciente vinha desenvolvendo febre com n&#243;dulos doloridos e evanescentes por todo o corpo&#46; O exame f&#237;sico geral tamb&#233;m revelou infiltra&#231;&#227;o difusa com madarose supraciliar &#40;<a class="elsevierStyleCrossRef" href="#fig0005">fig&#46; 1</a>&#41;&#46; O exame sensorial mostrou padr&#227;o de hipoestesia com distribui&#231;&#227;o em luva e meia&#46; O exame neurol&#243;gico mostrou espessamento leve sim&#233;trico bilateral dos nervos ulnar e fibular comum&#44; mas nenhuma sensibilidade&#44; e a for&#231;a nos m&#250;sculos das m&#227;os e dos p&#233;s estava dentro do limite normal&#46; O paciente foi diagnosticado como um caso de hansen&#237;ase virchowiana com ENH&#46; As investiga&#231;&#245;es de rotina estavam dentro dos limites normais&#44; exceto leucocitose e &#237;ndice bacteriol&#243;gico &#40;IB&#41; 5<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>&#46; De acordo com a escala de gravidade do <span class="elsevierStyleItalic">Erythema Nodosum Leprosum International Study</span> &#40;ENLIST&#41;&#44; dor<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>3&#44; febre<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>3&#44; les&#245;es<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>2&#44; inflama&#231;&#227;o<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>3&#44; extens&#227;o da les&#227;o<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>2&#44; edema perif&#233;rico<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>1&#44; dor &#243;ssea<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>1&#44; artrite<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>1&#44; linfadenopatia<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0 e neurite<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44; o escore foi 16&#46;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">3</span></a></p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0020" class="elsevierStylePara elsevierViewall">O paciente iniciou tratamento com talidomida 300<span class="elsevierStyleHsp" style=""></span>mg&#47;dia&#44; MB&#8208;TMD com 300<span class="elsevierStyleHsp" style=""></span>mg&#47;dia de clofazimina&#44; metilprednisolona 32<span class="elsevierStyleHsp" style=""></span>mg e analg&#233;sicos para al&#237;vio da dor&#46; Ap&#243;s duas semanas&#44; o paciente come&#231;ou a desenvolver neurite ulnar com aumento de dorm&#234;ncia tanto nas m&#227;os quanto nos p&#233;s&#46; Por isso&#44; a talidomida foi interrompida e minociclina 100<span class="elsevierStyleHsp" style=""></span>mg foi iniciada&#46; Entretanto&#44; n&#227;o houve melhora no ENH ap&#243;s um m&#234;s&#46; Em seguida&#44; o paciente tamb&#233;m come&#231;ou a receber metotrexato oral 15<span class="elsevierStyleHsp" style=""></span>mg&#47;semana&#46; Mesmo ap&#243;s quatro semanas de tratamento com uma combina&#231;&#227;o de metilprednisolona&#44; metotrexato&#44; minociclina&#44; analg&#233;sico e MB&#8208;TMD&#44; a condi&#231;&#227;o do paciente permaneceu a mesma&#44; com o aparecimento frequente de les&#245;es&#46; Em seguida&#44; todos os medicamentos foram interrompidos&#44; exceto a TMD e os analg&#233;sicos&#44; e a vacina&#231;&#227;o MIP foi planejada ap&#243;s obtermos o consentimento&#46; O paciente recebeu a vacina para MIP&#44; 0&#44;1<span class="elsevierStyleHsp" style=""></span>mL por via intrad&#233;rmica em ambos os bra&#231;os &#40;ao redor da inser&#231;&#227;o do m&#250;sculo deltoide&#41;&#46; O paciente n&#227;o se queixou de nenhum efeito colateral decorrente da vacina&#231;&#227;o&#46; A condi&#231;&#227;o do paciente melhorou muito ap&#243;s duas semanas &#40;<a class="elsevierStyleCrossRef" href="#fig0010">fig&#46; 2</a>&#41;&#46; Posteriormente&#44; ele recebeu TMD potencializada com minociclina e analg&#233;sicos pelos seis meses seguintes&#46; No seguimento posterior &#40;ap&#243;s dura&#231;&#227;o total do tratamento de dois anos e tr&#234;s meses&#41;&#44; o paciente foi avaliado clinicamente e o IB foi reduzido para 4<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>sem recorr&#234;ncia&#46;</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Discuss&#227;o</span><p id="par0025" class="elsevierStylePara elsevierViewall">A OMS lan&#231;ou uma &#8220;Estrat&#233;gia global para a hansen&#237;ase 2016&#8211;2020&#8221; de 5 anos&#44; em abril de 2016&#44; intitulada &#8220;Acelera&#231;&#227;o rumo a um mundo sem hansen&#237;ase&#8221;&#46; Com base no total de casos no final de 2018&#44; a taxa de preval&#234;ncia da hansen&#237;ase corresponde a 0&#44;2&#47;10&#46;000&#44; de acordo com a OMS&#46;<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">4</span></a> A incid&#234;ncia de ENH em pacientes com hansen&#237;ase multibacilar &#233; de at&#233; 24&#37;&#46; O ENH pode ocorrer antes&#44; durante ou ap&#243;s o tratamento anti&#8208;hansen&#237;ase&#44; mas &#233; mais comum nos primeiros seis meses de tratamento&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">O ENH &#233; uma complica&#231;&#227;o inflamat&#243;ria imunomediada&#46; Ele ocorre em raz&#227;o da libera&#231;&#227;o de mediadores pr&#243;&#8208;inflamat&#243;rios&#44; como o fator de necrose tumoral &#40;TNF&#41;&#8208;alfa&#44; interferon &#40;IFN&#41;&#8208;gama e interleucinas &#40;IL&#41;&#8208;2&#44; IL&#8208;6 e IL&#8208;12&#44; IL&#8208;17&#46;<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">5</span></a> H&#225; um aumento da ativa&#231;&#227;o de c&#233;lulas T no ENH n&#227;o tratado&#46; A propor&#231;&#227;o de c&#233;lulas T regulat&#243;rias para c&#233;lulas T efetoras de mem&#243;ria diminuiu no ENH em compara&#231;&#227;o com os controles com hansen&#237;ase virchowiana &#40;HV&#41; e mais c&#233;lulas T s&#227;o ant&#237;geno&#8208;experientes no ENH&#46;<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">6</span></a></p><p id="par0035" class="elsevierStylePara elsevierViewall">Corticosteroide em altas doses s&#227;o a base do tratamento do ENH&#44; mas seu uso prolongado leva a s&#233;rios efeitos adversos e depend&#234;ncia de esteroides&#46; Os medicamentos de segunda linha&#44; como talidomida&#44; clofazimina&#44; pentoxifilina&#44; ciclofosfamida e metotrexato&#44; tamb&#233;m s&#227;o muito eficazes e usados como agentes poupadores de esteroides&#46;<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a> &#192;s vezes&#44; o ENH cr&#244;nico torna&#8208;se refrat&#225;rio aos medicamentos de segunda linha e representa um dilema terap&#234;utico&#46; Uma pesquisa bibliogr&#225;fica no PubMed revelou o papel de azatioprina&#44; inibidores do TNF&#8208;&#945;&#44; minociclina e apremilaste no tratamento do ENH recalcitrante cr&#244;nico&#44; mas alguns deles est&#227;o associados a efeitos adversos inaceit&#225;veis&#44; maior dura&#231;&#227;o e alto custo de tratamento &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">tabela 1</a>&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0085"><span class="elsevierStyleSup">7&#8211;9</span></a></p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0040" class="elsevierStylePara elsevierViewall">A vacina para MIP &#233; uma suspens&#227;o autoclavada de micobact&#233;rias n&#227;o patog&#234;nicas&#46; Ela modula a resposta imune celular em dire&#231;&#227;o ao tipo protetor Th1&#44; que converte quase 98&#37; dos contatos saud&#225;veis normais lepromina&#8208;negativos para um estado lepromina&#8208;positivo&#46;<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">2</span></a> Anteriormente&#44; a vacina era evitada em rea&#231;&#245;es hans&#234;nicas&#44; pois havia a suspeita de que precipitasse as mesmas&#46; Mas a observa&#231;&#227;o do presente estudo sobre o uso de uma &#250;nica dose da vacina MIP no ENH recalcitrante cr&#244;nico fornece uma vis&#227;o sobre como eliminar o estado de rea&#231;&#227;o aguda da doen&#231;a tamb&#233;m&#46; O ENH &#233; desencadeado quando h&#225; abund&#226;ncia de bacilos fragmentados ou granulares nos tecidos&#46; Foi postulado&#44; ainda&#44; que h&#225; um desequil&#237;brio de subconjuntos de c&#233;lulas T imunorreguladoras no ENH&#46; Isso se manifesta como um aumento da propor&#231;&#227;o de c&#233;lulas T auxiliares &#40;CD4<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>&#41; para c&#233;lulas T&#8208;supressoras&#47;citot&#243;xicas &#40;CD8<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>&#41; no sangue&#46; Uma diminui&#231;&#227;o nas c&#233;lulas T CD8<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>pode favorecer a forma&#231;&#227;o e a deposi&#231;&#227;o de complexos imunes&#46; Ap&#243;s a imuniza&#231;&#227;o com a vacina para MIP&#44; h&#225; uma elimina&#231;&#227;o bacteriol&#243;gica acelerada e indu&#231;&#227;o de secre&#231;&#227;o de IFN&#8208;&#947;&#44; TNF&#8208;&#945; e IL&#8208;12&#44; maior atividade citot&#243;xica das c&#233;lulas NK e c&#233;lulas T CD8<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>e diminui&#231;&#227;o do recrutamento de c&#233;lulas B&#46;<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">10</span></a> Essa &#233; a poss&#237;vel explica&#231;&#227;o do papel da vacina para MIP no ENH&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">Como existem op&#231;&#245;es terap&#234;uticas limitadas no ENH&#44; a utiliza&#231;&#227;o dessa vacina em alguns casos resistentes ao tratamento s&#243; nos ajudar&#225; no futuro&#46; Embora este caso sugira que a vacina para MIP n&#227;o &#233; apenas uma modalidade preventiva&#44; mas tamb&#233;m uma terapia complementar a outros regimes anti&#8208;ENH&#44; ser&#227;o necess&#225;rios ensaios cl&#237;nicos randomizados futuros para explorar mais possibilidades com essa vacina&#46;</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Suporte financeiro</span><p id="par0050" class="elsevierStylePara elsevierViewall">Nenhum&#46;</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Contribui&#231;&#245;es dos autores</span><p id="par0055" class="elsevierStylePara elsevierViewall">Sunil Kumar Gupta&#58; Concep&#231;&#227;o e planejamento do estudo&#44; obten&#231;&#227;o&#44; an&#225;lise e interpreta&#231;&#227;o dos dados&#59; reda&#231;&#227;o do manuscrito&#46;</p><p id="par0060" class="elsevierStylePara elsevierViewall">Sushantika Kumari&#58; Concep&#231;&#227;o e planejamento do estudo&#44; obten&#231;&#227;o&#44; an&#225;lise e interpreta&#231;&#227;o dos dados&#59; reda&#231;&#227;o do manuscrito&#46;</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Conflito de interesses</span><p id="par0065" class="elsevierStylePara elsevierViewall">Nenhum&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:9 [
        0 => array:3 [
          "identificador" => "xres1658794"
          "titulo" => "Resumo"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0005"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec1474337"
          "titulo" => "Palavras&#8208;chave"
        ]
        2 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introdu&#231;&#227;o"
        ]
        3 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Relato do caso"
        ]
        4 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Discuss&#227;o"
        ]
        5 => array:2 [
          "identificador" => "sec0020"
          "titulo" => "Suporte financeiro"
        ]
        6 => array:2 [
          "identificador" => "sec0025"
          "titulo" => "Contribui&#231;&#245;es dos autores"
        ]
        7 => array:2 [
          "identificador" => "sec0030"
          "titulo" => "Conflito de interesses"
        ]
        8 => array:1 [
          "titulo" => "Refer&#234;ncias"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2020-07-16"
    "fechaAceptado" => "2020-08-24"
    "PalabrasClave" => array:1 [
      "pt" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palavras&#8208;chave"
          "identificador" => "xpalclavsec1474337"
          "palabras" => array:4 [
            0 => "Eritema nodoso"
            1 => "Hansen&#237;ase"
            2 => "Infec&#231;&#245;es por <span class="elsevierStyleItalic">Mycobacterium</span>"
            3 => "Vacinas"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:1 [
      "pt" => array:2 [
        "titulo" => "Resumo"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">O eritema nodoso hans&#234;nico &#233; uma rea&#231;&#227;o imunol&#243;gica grave que complica o curso normal da hansen&#237;ase multibacilar&#46; H&#225; um aumento da ativa&#231;&#227;o das c&#233;lulas T no eritema nodoso hans&#234;nico&#46; As modalidades de tratamento dispon&#237;veis at&#233; o momento para o manejo s&#227;o esteroides sist&#234;micos&#44; talidomida&#44; metotrexato&#44; ciclofosfamida&#44; azatioprina&#44; minociclina e apremilaste&#44; mas nenhum deles &#233; promissor e seguro&#46; <span class="elsevierStyleItalic">Mycobacterium indicus pranii</span> &#233; uma micobact&#233;ria at&#237;pica com fortes propriedades imunomoduladoras&#46; A vacina para esta micobact&#233;ria demonstrou ter efeitos imunoterap&#234;uticos e imunoprofil&#225;ticos em pacientes com hansen&#237;ase multibacilar&#46; Este relato de caso descreve um paciente com eritema nodoso hans&#234;nico recalcitrante cr&#244;nico que respondeu &#224; vacina para <span class="elsevierStyleItalic">Mycobacterium indicus pranii</span> sem quaisquer efeitos adversos&#44; sugerindo seu papel como nova op&#231;&#227;o terap&#234;utica nessa rea&#231;&#227;o&#46;</p></span>"
      ]
    ]
    "NotaPie" => array:2 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Como citar este artigo&#58; Gupta SK&#44; Kumari S&#46; Chronic recalcitrant erythema nodosum leprosum&#58; therapeutic dilemma and role of <span class="elsevierStyleItalic">mycobacterium indicus pranii</span> vaccine&#46; An Bras Dermatol&#46; 2022&#59;97&#58;49&#8211;53&#46;</p>"
      ]
      1 => array:2 [
        "etiqueta" => "&#9734;&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Trabalho realizado no All&#8208;India Institute of Medical Sciences&#44; Gorakhpur&#44; UP&#44; &#205;ndia&#46;</p>"
      ]
    ]
    "multimedia" => array:3 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figura 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1546
            "Ancho" => 2174
            "Tamanyo" => 488502
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Hansen&#237;ase virchowiana com ENH mostrando as les&#245;es antes da vacina&#231;&#227;o&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figura 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1772
            "Ancho" => 2174
            "Tamanyo" => 557443
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Hansen&#237;ase virchowiana com ENH mostrando a elimina&#231;&#227;o das les&#245;es ap&#243;s a vacina MIP&#46;</p>"
        ]
      ]
      2 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Tabela 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Tabela "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">HV&#44; hansen&#237;ase virchowiana&#59; HBV&#44; hansen&#237;ase borderline virchowiana&#59; ENH&#44; eritema nodoso hans&#234;nico&#59; IB&#44; &#237;ndice bacteriol&#243;gico&#59; i&#46;v&#46;&#44; intravenoso&#59; s&#46;c&#46;&#44; subcut&#226;neo&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Medicamento&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Refer&#234;ncia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Tipo de estudo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Dose e dura&#231;&#227;o&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Pacientes&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Tipo de hansen&#237;ase e dura&#231;&#227;o&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">ENH refrat&#225;rio a medicamentos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">IB&#8208;pr&#233;&#47;p&#243;s&#8208;tratamento&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Infliximabe</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Faber WR et al&#46; N Engl J Med&#46; 2006&#59;355&#58;739</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Relato de caso &#40;<span class="elsevierStyleItalic">letter</span>&#41;</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">300<span class="elsevierStyleHsp" style=""></span>mg i&#46;v&#46; nas semanas&#160;1&#44; 2&#44; e 6</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">52 anos&#44; sexo feminino</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">HBV&#44; 8&#160;meses</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Prednisolona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">5<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>&#47;n&#227;o dispon&#237;vel</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Talidomida&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Pentoxifilina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="13" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Etanercepte</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Michele L et al&#46; Clinical Infectious Diseases&#44; 2011&#59;52&#40;5&#41;&#58;e133&#8208;5</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Relato de caso</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">50&#160;mg&#47;semana s&#46;c&#46;<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>2&#160;anos</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">33 anos sexo feminino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">HV&#44; 2&#160;meses</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Prednisona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>a 4<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>&#47; n&#227;o dispon&#237;vel</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Talidomida&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Clofazimina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="8" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Chowdhry S et al&#46; Int J Mycobacteriol&#44;2016&#59;5&#40;2&#41;&#58;223&#8208;5</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="8" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Relato de caso</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="8" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">50&#160;mg&#47;semana s&#46;c&#46;<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>16&#160;semanas</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="8" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">49 anos&#44; sexo masculino</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="8" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">HV&#44; 2&#160;meses</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Prednisolona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="8" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>&#47;n&#227;o dispon&#237;vel</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Clofazimina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Talidomida&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Minociclina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Claritromicina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Ofloxacina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Pentoxifilina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Azatioprina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Santos JRS et al&#46; An Bras Dermatol&#46; 2017&#59;92&#40;4&#41;&#58;575&#8208;7</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Relato de caso</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">50&#160;mg&#47;semana s&#46;c&#46;<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>11&#160;meses</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">40 anos&#44; sexo masculino</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">HV&#44; 1&#160;ano</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Prednisolona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">N&#227;o dispon&#237;vel</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Talidomida&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="7" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Minociclina</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="7" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Narang T et al JAMA Dermatol&#46; 2015&#59;151&#40;9&#41;&#58; 1026&#8208;8</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="7" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Estudo piloto prospectivo</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="7" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">100&#160;mg&#47;dia<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>3&#160;meses</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="7" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">10 pacientes</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="7" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">8&#160;HV<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>1&#160;HBV<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>1 histoide no &#250;ltimo ano</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Prednisolona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="7" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>&#47; diminui&#231;&#227;o de 1&#160;log</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Clofazimina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Talidomida&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Pentoxifilina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Colchicina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Hidroxicloroquina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Azatioprina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Azatioprina</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Jitendra SSV et al&#46; J Clin Diagn Res&#46; 2017&#59;11&#40;8&#41;&#58;FD01&#8208;FD02</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Relato de caso</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">100&#160;mg&#47;dia<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>12&#160;meses</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">48 anos&#44; sexo masculino</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">HV&#44; 4&#160;anos</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Prednisolona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>&#47;n&#227;o dispon&#237;vel</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Clofazimina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Talidomida&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="6" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Apremilaste</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="6" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Narang T et al&#46; Br J Dermatol&#46; 2020&#59;182&#40;4&#41;&#58;1034&#8208;7</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="6" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Relato de caso</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="6" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">30&#160;mg BID 2<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>&#47;dia seguida do escalonamento da dose padr&#227;o na primeira semana<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>5&#160;meses</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">34 anos&#44; sexo masculino</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">HV&#44; 8&#160;meses</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Prednisolona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="6" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">N&#227;o dispon&#237;vel</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Clofazimina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Colchicina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">31 anos&#44; sexo masculino</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">HV&#44; 12&#160;meses</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Minociclina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Pentoxifilina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Talidomida&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2824199.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Lista de medicamentos experimentados no ENH recalcitrante cr&#244;nico</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Refer&#234;ncias"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:10 [
            0 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Interventions for erythema nodosum leprosum"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "N&#46;H&#46;J&#46; Veen"
                            1 => "D&#46;N&#46;J&#46; Lockwood"
                            2 => "W&#46;H&#46; Brakel"
                            3 => "J&#46; Ramirez Junior"
                            4 => "J&#46;H&#46; Richardus"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Cochrane Database Syst Rev&#46;"
                        "fecha" => "2009"
                        "volumen" => "8"
                        "paginaInicial" => "6949"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical and histopathological evaluation of the effect of addition of immunotherapy with Mw vaccine to standard chemotherapy in borderline leprosy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "R&#46; Kamal"
                            1 => "M&#46; Natrajan"
                            2 => "K&#46; Katoch"
                            3 => "M&#46; Arora"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Indian J Lepr&#46;"
                        "fecha" => "2012"
                        "volumen" => "84"
                        "paginaInicial" => "287"
                        "paginaFinal" => "306"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Epidemiological profile and severity of erythema nodosum leprosum in Brazil&#58; a cross&#8208;sectional study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "C&#46; Baima de Melo"
                            1 => "B&#46;D&#46; Silva de S&#225;"
                            2 => "F&#46;A&#46;C&#46; Costa"
                            3 => "E&#46;N&#46; Sarno"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/ijd.14895"
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Dermatol&#46;"
                        "fecha" => "2020"
                        "volumen" => "59"
                        "paginaInicial" => "856"
                        "paginaFinal" => "861"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32358972"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Current Situation of Leprosy in India and its Future Implications"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "P&#46;N&#46; Rao"
                            1 => "S&#46; Suneetha"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.4103/idoj.IDOJ_282_17"
                      "Revista" => array:6 [
                        "tituloSerie" => "Indian Dermatol Online J&#46;"
                        "fecha" => "2018"
                        "volumen" => "9"
                        "paginaInicial" => "83"
                        "paginaFinal" => "89"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29644191"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "A&#46; Polycarpou"
                            1 => "S&#46;L&#46; Walker"
                            2 => "D&#46;N&#46;J&#46; Lockwood"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3389/fimmu.2017.00233"
                      "Revista" => array:5 [
                        "tituloSerie" => "Front Immunol&#46;"
                        "fecha" => "2017"
                        "volumen" => "8"
                        "paginaInicial" => "233"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28348555"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "New Insight into the Pathogenesis of Erythema Nodosum Leprosum&#58; The Role of Activated Memory T&#8208;Cells"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "E&#46; Negera"
                            1 => "K&#46; Bobosha"
                            2 => "S&#46;L&#46; Walker"
                            3 => "B&#46; Endale"
                            4 => "R&#46; Howe"
                            5 => "A&#46; Aseffa"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3389/fimmu.2017.01149"
                      "Revista" => array:5 [
                        "tituloSerie" => "Front Immunol&#46;"
                        "fecha" => "2017"
                        "volumen" => "8"
                        "paginaInicial" => "1149"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28966621"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Etanercept in erythema nodosum leprosum"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "J&#46;R&#46;S&#46; Santos"
                            1 => "D&#46;L&#46; Vendramini"
                            2 => "J&#46;A&#46;D&#46;C&#46; Nery"
                            3 => "J&#46;C&#46;R&#46; Avelleira"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1590/abd1806-4841.20175471"
                      "Revista" => array:6 [
                        "tituloSerie" => "An Bras Dermatol&#46;"
                        "fecha" => "2017"
                        "volumen" => "92"
                        "paginaInicial" => "575"
                        "paginaFinal" => "577"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28954119"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Apremilast in chronic recalcitrant erythema nodosum leprosum&#58; a report of two cases"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "T&#46; Narang"
                            1 => "A&#46; Kaushik"
                            2 => "S&#46; Dogra"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/bjd.18233"
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Dermatol&#46;"
                        "fecha" => "2020"
                        "volumen" => "182"
                        "paginaInicial" => "1034"
                        "paginaFinal" => "1037"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31218666"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Azathioprine in Chronic Recalcitrant Erythema Nodosum Leprosum&#58; A Case Report"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "S&#46;S&#46;V&#46; Jitendra"
                            1 => "R&#46; Bachaspatimayum"
                            2 => "A&#46;S&#46; Devi"
                            3 => "S&#46; Rita"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.7860/JCDR/2017/26536.10499"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Clin Diagn Res&#46;"
                        "fecha" => "2017"
                        "volumen" => "11"
                        "paginaInicial" => "FD01"
                        "paginaFinal" => "FD02"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28969152"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Mycobacterium indicus pranii protein MIP&#95;05962 induces Th1 cell mediated immune response in mice"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "A&#46; Sharma"
                            1 => "M&#46; Saqib"
                            2 => "J&#46;A&#46; Sheikh"
                            3 => "N&#46;Z&#46; Ehtesham"
                            4 => "S&#46; Bhaskar"
                            5 => "T&#46;K&#46; Chaudhuri"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.ijmm.2018.08.008"
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Med Microbiol&#46;"
                        "fecha" => "2018"
                        "volumen" => "308"
                        "paginaInicial" => "1000"
                        "paginaFinal" => "1008"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30190103"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "pt"
  "url" => "/26662752/0000009700000001/v1_202202030913/S2666275221002629/v1_202202030913/pt/main.assets"
  "Apartado" => array:4 [
    "identificador" => "81736"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Caso Cl&#237;nico"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/26662752/0000009700000001/v1_202202030913/S2666275221002629/v1_202202030913/pt/main.pdf?idApp=UINPBA00008Z&text.app=https://clinics.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275221002629?idApp=UINPBA00008Z"
]
Compartilhar
Informação da revista

Estatísticas

Siga este link para acessar o texto completo do artigo

Caso Clínico
Eritema nodoso hansênico recalcitrante crônico: dilema terapêutico e papel da vacina para Mycobacterium indicus pranii
Sunil Kumar Gupta
Autor para correspondência
dr.sunil_30@yahoo.co.in

Autor para correspondência.
, Sushantika Kumari
Departamento de Dermatologia, All India Institute of Medical Sciences, Gorakhpur, Índia
Lido
13595
Vezes
que se leu este artigo
2711
Total PDF
10884
Total HTML
Compartilhar estatísticas
 array:24 [
  "pii" => "S2666275221002629"
  "issn" => "26662752"
  "doi" => "10.1016/j.abdp.2021.11.006"
  "estado" => "S300"
  "fechaPublicacion" => "2022-01-01"
  "aid" => "465"
  "copyright" => "Sociedade Brasileira de Dermatologia"
  "copyrightAnyo" => "2021"
  "documento" => "simple-article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by/4.0/"
  "subdocumento" => "crp"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "en" => array:19 [
      "pii" => "S0365059621002579"
      "issn" => "03650596"
      "doi" => "10.1016/j.abd.2020.08.032"
      "estado" => "S300"
      "fechaPublicacion" => "2022-01-01"
      "aid" => "465"
      "copyright" => "Sociedade Brasileira de Dermatologia"
      "documento" => "simple-article"
      "crossmark" => 1
      "licencia" => "http://creativecommons.org/licenses/by/4.0/"
      "subdocumento" => "crp"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:1 [
        "total" => 0
      ]
      "en" => array:12 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Case Report</span>"
        "titulo" => "Chronic recalcitrant erythema nodosum leprosum&#58; therapeutic dilemma and role of <span class="elsevierStyleItalic">mycobacterium indicus pranii</span> vaccine"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "tieneResumen" => "en"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "49"
            "paginaFinal" => "53"
          ]
        ]
        "contieneResumen" => array:1 [
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:8 [
            "identificador" => "fig0005"
            "etiqueta" => "Figure 1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr1.jpeg"
                "Alto" => 1546
                "Ancho" => 2174
                "Tamanyo" => 487304
              ]
            ]
            "detalles" => array:1 [
              0 => array:3 [
                "identificador" => "at0005"
                "detalle" => "Figure "
                "rol" => "short"
              ]
            ]
            "descripcion" => array:1 [
              "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Lepromatous Leprosy with ENL showing lesions before vaccination&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Sunil Kumar Gupta, Sushantika Kumari"
            "autores" => array:2 [
              0 => array:2 [
                "nombre" => "Sunil Kumar"
                "apellidos" => "Gupta"
              ]
              1 => array:2 [
                "nombre" => "Sushantika"
                "apellidos" => "Kumari"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "pt" => array:9 [
          "pii" => "S2666275221002629"
          "doi" => "10.1016/j.abdp.2021.11.006"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "pt"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275221002629?idApp=UINPBA00008Z"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059621002579?idApp=UINPBA00008Z"
      "url" => "/03650596/0000009700000001/v1_202201230559/S0365059621002579/v1_202201230559/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S2666275221002654"
    "issn" => "26662752"
    "doi" => "10.1016/j.abdp.2021.11.009"
    "estado" => "S300"
    "fechaPublicacion" => "2022-01-01"
    "aid" => "468"
    "copyright" => "Sociedade Brasileira de Dermatologia"
    "documento" => "simple-article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by/4.0/"
    "subdocumento" => "crp"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "pt" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Caso Cl&#237;nico</span>"
      "titulo" => "Fen&#244;meno de L&#250;cio&#58; import&#226;ncia da aten&#231;&#227;o b&#225;sica e dermatol&#243;gica"
      "tienePdf" => "pt"
      "tieneTextoCompleto" => "pt"
      "tieneResumen" => "pt"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "54"
          "paginaFinal" => "57"
        ]
      ]
      "contieneResumen" => array:1 [
        "pt" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "pt" => true
      ]
      "contienePdf" => array:1 [
        "pt" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0010"
          "etiqueta" => "Figura 2"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr2.jpeg"
              "Alto" => 652
              "Ancho" => 900
              "Tamanyo" => 158290
            ]
          ]
          "descripcion" => array:1 [
            "pt" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Necrose no abdome&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Juliana Viana Pinheiro, Maria Araci de Andrade Pontes, Jos&#233; Urbano de Medeiros Neto, Heitor de S&#225; Gon&#231;alves"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Juliana Viana"
              "apellidos" => "Pinheiro"
            ]
            1 => array:2 [
              "nombre" => "Maria Araci de Andrade"
              "apellidos" => "Pontes"
            ]
            2 => array:2 [
              "nombre" => "Jos&#233; Urbano de"
              "apellidos" => "Medeiros Neto"
            ]
            3 => array:2 [
              "nombre" => "Heitor de S&#225;"
              "apellidos" => "Gon&#231;alves"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "pt"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0365059621002610"
        "doi" => "10.1016/j.abd.2020.08.033"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059621002610?idApp=UINPBA00008Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275221002654?idApp=UINPBA00008Z"
    "url" => "/26662752/0000009700000001/v1_202202030913/S2666275221002654/v1_202202030913/pt/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S2666275221002599"
    "issn" => "26662752"
    "doi" => "10.1016/j.abdp.2021.11.003"
    "estado" => "S300"
    "fechaPublicacion" => "2022-01-01"
    "aid" => "462"
    "copyright" => "Sociedade Brasileira de Dermatologia"
    "documento" => "simple-article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by/4.0/"
    "subdocumento" => "crp"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "pt" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Caso Cl&#237;nico</span>"
      "titulo" => "Hamartoma folicular basaloide associado a mucinose folicular e inflama&#231;&#227;o"
      "tienePdf" => "pt"
      "tieneTextoCompleto" => "pt"
      "tieneResumen" => "pt"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "45"
          "paginaFinal" => "48"
        ]
      ]
      "contieneResumen" => array:1 [
        "pt" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "pt" => true
      ]
      "contienePdf" => array:1 [
        "pt" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0010"
          "etiqueta" => "Figura 2"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr2.jpeg"
              "Alto" => 507
              "Ancho" => 900
              "Tamanyo" => 59279
            ]
          ]
          "descripcion" => array:1 [
            "pt" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Les&#227;o de cor laranja&#8208;rosada com forma&#231;&#227;o de escamas&#44; especialmente perifolicular&#44; sem padr&#227;o de les&#227;o melanoc&#237;tica ou vascular&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Solange Edelman, Adriana Natalia Torres Huamani, Mar&#237;a Del Valle Centeno, Andrea Bettina Cervini"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Solange"
              "apellidos" => "Edelman"
            ]
            1 => array:2 [
              "nombre" => "Adriana Natalia"
              "apellidos" => "Torres Huamani"
            ]
            2 => array:2 [
              "nombre" => "Mar&#237;a Del Valle"
              "apellidos" => "Centeno"
            ]
            3 => array:2 [
              "nombre" => "Andrea Bettina"
              "apellidos" => "Cervini"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "pt"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0365059621002543"
        "doi" => "10.1016/j.abd.2020.10.012"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059621002543?idApp=UINPBA00008Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275221002599?idApp=UINPBA00008Z"
    "url" => "/26662752/0000009700000001/v1_202202030913/S2666275221002599/v1_202202030913/pt/main.assets"
  ]
  "pt" => array:19 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Caso Cl&#237;nico</span>"
    "titulo" => "Eritema nodoso hans&#234;nico recalcitrante cr&#244;nico&#58; dilema terap&#234;utico e papel da vacina para <span class="elsevierStyleItalic">Mycobacterium indicus pranii</span>"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "49"
        "paginaFinal" => "53"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Sunil Kumar Gupta, Sushantika Kumari"
        "autores" => array:2 [
          0 => array:4 [
            "nombre" => "Sunil Kumar"
            "apellidos" => "Gupta"
            "email" => array:1 [
              0 => "dr.sunil_30@yahoo.co.in"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "Sushantika"
            "apellidos" => "Kumari"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Departamento de Dermatologia&#44; All India Institute of Medical Sciences&#44; Gorakhpur&#44; &#205;ndia"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Autor para correspond&#234;ncia&#46;"
          ]
        ]
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figura 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1772
            "Ancho" => 2174
            "Tamanyo" => 557443
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Hansen&#237;ase virchowiana com ENH mostrando a elimina&#231;&#227;o das les&#245;es ap&#243;s a vacina MIP&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Introdu&#231;&#227;o</span><p id="par0005" class="elsevierStylePara elsevierViewall">A hansen&#237;ase &#233; uma doen&#231;a infecciosa causada por <span class="elsevierStyleItalic">Mycobacterium leprae</span>&#46; A doen&#231;a afeta os nervos perif&#233;ricos&#44; a pele&#44; a mucosa do trato respirat&#243;rio superior e os olhos&#46; O curso indolente da doen&#231;a &#233; interrompido por surtos agudos denominados rea&#231;&#245;es hans&#234;nicas &#40;rea&#231;&#227;o reversa e eritema nodoso hans&#234;nico &#91;ENH&#93;&#41;&#46; O ENH &#233; caracterizado por conjuntos de p&#225;pulas e n&#243;dulos doloridos&#44; febre alta e outros sintomas constitucionais&#46; O tratamento do ENH recalcitrante cr&#244;nico &#233; dif&#237;cil e geralmente requer agentes sist&#234;micos como corticosteroides&#44; talidomida&#44; clofazimina&#44; minociclina ou imunomoduladores&#44; sozinhos ou em combina&#231;&#227;o&#44; por muitos meses&#46;<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a> A vacina para <span class="elsevierStyleItalic">Mycobacterium indicus pranii</span> &#40;MIP&#41; demonstrou ter efeitos imunoterap&#234;uticos e imunoprofil&#225;ticos em pacientes com hansen&#237;ase multibacilar&#46;<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">2</span></a> Ela tamb&#233;m reduziu a carga bacilar&#44; melhorou as les&#245;es a n&#237;vel imuno&#8208;histol&#243;gico&#44; levou &#224; elimina&#231;&#227;o completa do granuloma e reduziu a dura&#231;&#227;o da terapia multidrogas &#40;TMD&#41; em pacientes com hansen&#237;ase&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">Essa vacina n&#227;o foi amplamente testada em pacientes com rea&#231;&#245;es hans&#234;nicas&#44; pois havia o risco de precipitar uma rea&#231;&#227;o grave ap&#243;s a vacina&#231;&#227;o&#46; Nesse caso&#44; a vacina foi testada em um paciente com ENH que era dependente de esteroides e refrat&#225;rio &#224; talidomida e outros medicamentos de segunda linha&#44; e um resultado muito satisfat&#243;rio foi verificado com uma &#250;nica dose da vacina para MIP&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Relato do caso</span><p id="par0015" class="elsevierStylePara elsevierViewall">Um homem de 55 anos procurou o ambulat&#243;rio de dermatologia com hist&#243;ria de hansen&#237;ase&#44; para a qual fazia uso de TMD havia um ano e meio&#46; Nos &#250;ltimos 8 meses&#44; o paciente vinha desenvolvendo febre com n&#243;dulos doloridos e evanescentes por todo o corpo&#46; O exame f&#237;sico geral tamb&#233;m revelou infiltra&#231;&#227;o difusa com madarose supraciliar &#40;<a class="elsevierStyleCrossRef" href="#fig0005">fig&#46; 1</a>&#41;&#46; O exame sensorial mostrou padr&#227;o de hipoestesia com distribui&#231;&#227;o em luva e meia&#46; O exame neurol&#243;gico mostrou espessamento leve sim&#233;trico bilateral dos nervos ulnar e fibular comum&#44; mas nenhuma sensibilidade&#44; e a for&#231;a nos m&#250;sculos das m&#227;os e dos p&#233;s estava dentro do limite normal&#46; O paciente foi diagnosticado como um caso de hansen&#237;ase virchowiana com ENH&#46; As investiga&#231;&#245;es de rotina estavam dentro dos limites normais&#44; exceto leucocitose e &#237;ndice bacteriol&#243;gico &#40;IB&#41; 5<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>&#46; De acordo com a escala de gravidade do <span class="elsevierStyleItalic">Erythema Nodosum Leprosum International Study</span> &#40;ENLIST&#41;&#44; dor<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>3&#44; febre<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>3&#44; les&#245;es<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>2&#44; inflama&#231;&#227;o<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>3&#44; extens&#227;o da les&#227;o<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>2&#44; edema perif&#233;rico<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>1&#44; dor &#243;ssea<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>1&#44; artrite<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>1&#44; linfadenopatia<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0 e neurite<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44; o escore foi 16&#46;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">3</span></a></p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0020" class="elsevierStylePara elsevierViewall">O paciente iniciou tratamento com talidomida 300<span class="elsevierStyleHsp" style=""></span>mg&#47;dia&#44; MB&#8208;TMD com 300<span class="elsevierStyleHsp" style=""></span>mg&#47;dia de clofazimina&#44; metilprednisolona 32<span class="elsevierStyleHsp" style=""></span>mg e analg&#233;sicos para al&#237;vio da dor&#46; Ap&#243;s duas semanas&#44; o paciente come&#231;ou a desenvolver neurite ulnar com aumento de dorm&#234;ncia tanto nas m&#227;os quanto nos p&#233;s&#46; Por isso&#44; a talidomida foi interrompida e minociclina 100<span class="elsevierStyleHsp" style=""></span>mg foi iniciada&#46; Entretanto&#44; n&#227;o houve melhora no ENH ap&#243;s um m&#234;s&#46; Em seguida&#44; o paciente tamb&#233;m come&#231;ou a receber metotrexato oral 15<span class="elsevierStyleHsp" style=""></span>mg&#47;semana&#46; Mesmo ap&#243;s quatro semanas de tratamento com uma combina&#231;&#227;o de metilprednisolona&#44; metotrexato&#44; minociclina&#44; analg&#233;sico e MB&#8208;TMD&#44; a condi&#231;&#227;o do paciente permaneceu a mesma&#44; com o aparecimento frequente de les&#245;es&#46; Em seguida&#44; todos os medicamentos foram interrompidos&#44; exceto a TMD e os analg&#233;sicos&#44; e a vacina&#231;&#227;o MIP foi planejada ap&#243;s obtermos o consentimento&#46; O paciente recebeu a vacina para MIP&#44; 0&#44;1<span class="elsevierStyleHsp" style=""></span>mL por via intrad&#233;rmica em ambos os bra&#231;os &#40;ao redor da inser&#231;&#227;o do m&#250;sculo deltoide&#41;&#46; O paciente n&#227;o se queixou de nenhum efeito colateral decorrente da vacina&#231;&#227;o&#46; A condi&#231;&#227;o do paciente melhorou muito ap&#243;s duas semanas &#40;<a class="elsevierStyleCrossRef" href="#fig0010">fig&#46; 2</a>&#41;&#46; Posteriormente&#44; ele recebeu TMD potencializada com minociclina e analg&#233;sicos pelos seis meses seguintes&#46; No seguimento posterior &#40;ap&#243;s dura&#231;&#227;o total do tratamento de dois anos e tr&#234;s meses&#41;&#44; o paciente foi avaliado clinicamente e o IB foi reduzido para 4<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>sem recorr&#234;ncia&#46;</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Discuss&#227;o</span><p id="par0025" class="elsevierStylePara elsevierViewall">A OMS lan&#231;ou uma &#8220;Estrat&#233;gia global para a hansen&#237;ase 2016&#8211;2020&#8221; de 5 anos&#44; em abril de 2016&#44; intitulada &#8220;Acelera&#231;&#227;o rumo a um mundo sem hansen&#237;ase&#8221;&#46; Com base no total de casos no final de 2018&#44; a taxa de preval&#234;ncia da hansen&#237;ase corresponde a 0&#44;2&#47;10&#46;000&#44; de acordo com a OMS&#46;<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">4</span></a> A incid&#234;ncia de ENH em pacientes com hansen&#237;ase multibacilar &#233; de at&#233; 24&#37;&#46; O ENH pode ocorrer antes&#44; durante ou ap&#243;s o tratamento anti&#8208;hansen&#237;ase&#44; mas &#233; mais comum nos primeiros seis meses de tratamento&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">O ENH &#233; uma complica&#231;&#227;o inflamat&#243;ria imunomediada&#46; Ele ocorre em raz&#227;o da libera&#231;&#227;o de mediadores pr&#243;&#8208;inflamat&#243;rios&#44; como o fator de necrose tumoral &#40;TNF&#41;&#8208;alfa&#44; interferon &#40;IFN&#41;&#8208;gama e interleucinas &#40;IL&#41;&#8208;2&#44; IL&#8208;6 e IL&#8208;12&#44; IL&#8208;17&#46;<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">5</span></a> H&#225; um aumento da ativa&#231;&#227;o de c&#233;lulas T no ENH n&#227;o tratado&#46; A propor&#231;&#227;o de c&#233;lulas T regulat&#243;rias para c&#233;lulas T efetoras de mem&#243;ria diminuiu no ENH em compara&#231;&#227;o com os controles com hansen&#237;ase virchowiana &#40;HV&#41; e mais c&#233;lulas T s&#227;o ant&#237;geno&#8208;experientes no ENH&#46;<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">6</span></a></p><p id="par0035" class="elsevierStylePara elsevierViewall">Corticosteroide em altas doses s&#227;o a base do tratamento do ENH&#44; mas seu uso prolongado leva a s&#233;rios efeitos adversos e depend&#234;ncia de esteroides&#46; Os medicamentos de segunda linha&#44; como talidomida&#44; clofazimina&#44; pentoxifilina&#44; ciclofosfamida e metotrexato&#44; tamb&#233;m s&#227;o muito eficazes e usados como agentes poupadores de esteroides&#46;<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a> &#192;s vezes&#44; o ENH cr&#244;nico torna&#8208;se refrat&#225;rio aos medicamentos de segunda linha e representa um dilema terap&#234;utico&#46; Uma pesquisa bibliogr&#225;fica no PubMed revelou o papel de azatioprina&#44; inibidores do TNF&#8208;&#945;&#44; minociclina e apremilaste no tratamento do ENH recalcitrante cr&#244;nico&#44; mas alguns deles est&#227;o associados a efeitos adversos inaceit&#225;veis&#44; maior dura&#231;&#227;o e alto custo de tratamento &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">tabela 1</a>&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0085"><span class="elsevierStyleSup">7&#8211;9</span></a></p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0040" class="elsevierStylePara elsevierViewall">A vacina para MIP &#233; uma suspens&#227;o autoclavada de micobact&#233;rias n&#227;o patog&#234;nicas&#46; Ela modula a resposta imune celular em dire&#231;&#227;o ao tipo protetor Th1&#44; que converte quase 98&#37; dos contatos saud&#225;veis normais lepromina&#8208;negativos para um estado lepromina&#8208;positivo&#46;<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">2</span></a> Anteriormente&#44; a vacina era evitada em rea&#231;&#245;es hans&#234;nicas&#44; pois havia a suspeita de que precipitasse as mesmas&#46; Mas a observa&#231;&#227;o do presente estudo sobre o uso de uma &#250;nica dose da vacina MIP no ENH recalcitrante cr&#244;nico fornece uma vis&#227;o sobre como eliminar o estado de rea&#231;&#227;o aguda da doen&#231;a tamb&#233;m&#46; O ENH &#233; desencadeado quando h&#225; abund&#226;ncia de bacilos fragmentados ou granulares nos tecidos&#46; Foi postulado&#44; ainda&#44; que h&#225; um desequil&#237;brio de subconjuntos de c&#233;lulas T imunorreguladoras no ENH&#46; Isso se manifesta como um aumento da propor&#231;&#227;o de c&#233;lulas T auxiliares &#40;CD4<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>&#41; para c&#233;lulas T&#8208;supressoras&#47;citot&#243;xicas &#40;CD8<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>&#41; no sangue&#46; Uma diminui&#231;&#227;o nas c&#233;lulas T CD8<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>pode favorecer a forma&#231;&#227;o e a deposi&#231;&#227;o de complexos imunes&#46; Ap&#243;s a imuniza&#231;&#227;o com a vacina para MIP&#44; h&#225; uma elimina&#231;&#227;o bacteriol&#243;gica acelerada e indu&#231;&#227;o de secre&#231;&#227;o de IFN&#8208;&#947;&#44; TNF&#8208;&#945; e IL&#8208;12&#44; maior atividade citot&#243;xica das c&#233;lulas NK e c&#233;lulas T CD8<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>e diminui&#231;&#227;o do recrutamento de c&#233;lulas B&#46;<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">10</span></a> Essa &#233; a poss&#237;vel explica&#231;&#227;o do papel da vacina para MIP no ENH&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">Como existem op&#231;&#245;es terap&#234;uticas limitadas no ENH&#44; a utiliza&#231;&#227;o dessa vacina em alguns casos resistentes ao tratamento s&#243; nos ajudar&#225; no futuro&#46; Embora este caso sugira que a vacina para MIP n&#227;o &#233; apenas uma modalidade preventiva&#44; mas tamb&#233;m uma terapia complementar a outros regimes anti&#8208;ENH&#44; ser&#227;o necess&#225;rios ensaios cl&#237;nicos randomizados futuros para explorar mais possibilidades com essa vacina&#46;</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Suporte financeiro</span><p id="par0050" class="elsevierStylePara elsevierViewall">Nenhum&#46;</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Contribui&#231;&#245;es dos autores</span><p id="par0055" class="elsevierStylePara elsevierViewall">Sunil Kumar Gupta&#58; Concep&#231;&#227;o e planejamento do estudo&#44; obten&#231;&#227;o&#44; an&#225;lise e interpreta&#231;&#227;o dos dados&#59; reda&#231;&#227;o do manuscrito&#46;</p><p id="par0060" class="elsevierStylePara elsevierViewall">Sushantika Kumari&#58; Concep&#231;&#227;o e planejamento do estudo&#44; obten&#231;&#227;o&#44; an&#225;lise e interpreta&#231;&#227;o dos dados&#59; reda&#231;&#227;o do manuscrito&#46;</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Conflito de interesses</span><p id="par0065" class="elsevierStylePara elsevierViewall">Nenhum&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:9 [
        0 => array:3 [
          "identificador" => "xres1658794"
          "titulo" => "Resumo"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0005"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec1474337"
          "titulo" => "Palavras&#8208;chave"
        ]
        2 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introdu&#231;&#227;o"
        ]
        3 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Relato do caso"
        ]
        4 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Discuss&#227;o"
        ]
        5 => array:2 [
          "identificador" => "sec0020"
          "titulo" => "Suporte financeiro"
        ]
        6 => array:2 [
          "identificador" => "sec0025"
          "titulo" => "Contribui&#231;&#245;es dos autores"
        ]
        7 => array:2 [
          "identificador" => "sec0030"
          "titulo" => "Conflito de interesses"
        ]
        8 => array:1 [
          "titulo" => "Refer&#234;ncias"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2020-07-16"
    "fechaAceptado" => "2020-08-24"
    "PalabrasClave" => array:1 [
      "pt" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palavras&#8208;chave"
          "identificador" => "xpalclavsec1474337"
          "palabras" => array:4 [
            0 => "Eritema nodoso"
            1 => "Hansen&#237;ase"
            2 => "Infec&#231;&#245;es por <span class="elsevierStyleItalic">Mycobacterium</span>"
            3 => "Vacinas"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:1 [
      "pt" => array:2 [
        "titulo" => "Resumo"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">O eritema nodoso hans&#234;nico &#233; uma rea&#231;&#227;o imunol&#243;gica grave que complica o curso normal da hansen&#237;ase multibacilar&#46; H&#225; um aumento da ativa&#231;&#227;o das c&#233;lulas T no eritema nodoso hans&#234;nico&#46; As modalidades de tratamento dispon&#237;veis at&#233; o momento para o manejo s&#227;o esteroides sist&#234;micos&#44; talidomida&#44; metotrexato&#44; ciclofosfamida&#44; azatioprina&#44; minociclina e apremilaste&#44; mas nenhum deles &#233; promissor e seguro&#46; <span class="elsevierStyleItalic">Mycobacterium indicus pranii</span> &#233; uma micobact&#233;ria at&#237;pica com fortes propriedades imunomoduladoras&#46; A vacina para esta micobact&#233;ria demonstrou ter efeitos imunoterap&#234;uticos e imunoprofil&#225;ticos em pacientes com hansen&#237;ase multibacilar&#46; Este relato de caso descreve um paciente com eritema nodoso hans&#234;nico recalcitrante cr&#244;nico que respondeu &#224; vacina para <span class="elsevierStyleItalic">Mycobacterium indicus pranii</span> sem quaisquer efeitos adversos&#44; sugerindo seu papel como nova op&#231;&#227;o terap&#234;utica nessa rea&#231;&#227;o&#46;</p></span>"
      ]
    ]
    "NotaPie" => array:2 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Como citar este artigo&#58; Gupta SK&#44; Kumari S&#46; Chronic recalcitrant erythema nodosum leprosum&#58; therapeutic dilemma and role of <span class="elsevierStyleItalic">mycobacterium indicus pranii</span> vaccine&#46; An Bras Dermatol&#46; 2022&#59;97&#58;49&#8211;53&#46;</p>"
      ]
      1 => array:2 [
        "etiqueta" => "&#9734;&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Trabalho realizado no All&#8208;India Institute of Medical Sciences&#44; Gorakhpur&#44; UP&#44; &#205;ndia&#46;</p>"
      ]
    ]
    "multimedia" => array:3 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figura 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1546
            "Ancho" => 2174
            "Tamanyo" => 488502
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Hansen&#237;ase virchowiana com ENH mostrando as les&#245;es antes da vacina&#231;&#227;o&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figura 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1772
            "Ancho" => 2174
            "Tamanyo" => 557443
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Hansen&#237;ase virchowiana com ENH mostrando a elimina&#231;&#227;o das les&#245;es ap&#243;s a vacina MIP&#46;</p>"
        ]
      ]
      2 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Tabela 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Tabela "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">HV&#44; hansen&#237;ase virchowiana&#59; HBV&#44; hansen&#237;ase borderline virchowiana&#59; ENH&#44; eritema nodoso hans&#234;nico&#59; IB&#44; &#237;ndice bacteriol&#243;gico&#59; i&#46;v&#46;&#44; intravenoso&#59; s&#46;c&#46;&#44; subcut&#226;neo&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Medicamento&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Refer&#234;ncia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Tipo de estudo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Dose e dura&#231;&#227;o&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Pacientes&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Tipo de hansen&#237;ase e dura&#231;&#227;o&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">ENH refrat&#225;rio a medicamentos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">IB&#8208;pr&#233;&#47;p&#243;s&#8208;tratamento&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Infliximabe</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Faber WR et al&#46; N Engl J Med&#46; 2006&#59;355&#58;739</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Relato de caso &#40;<span class="elsevierStyleItalic">letter</span>&#41;</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">300<span class="elsevierStyleHsp" style=""></span>mg i&#46;v&#46; nas semanas&#160;1&#44; 2&#44; e 6</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">52 anos&#44; sexo feminino</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">HBV&#44; 8&#160;meses</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Prednisolona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">5<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>&#47;n&#227;o dispon&#237;vel</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Talidomida&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Pentoxifilina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="13" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Etanercepte</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Michele L et al&#46; Clinical Infectious Diseases&#44; 2011&#59;52&#40;5&#41;&#58;e133&#8208;5</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Relato de caso</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">50&#160;mg&#47;semana s&#46;c&#46;<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>2&#160;anos</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">33 anos sexo feminino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">HV&#44; 2&#160;meses</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Prednisona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>a 4<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>&#47; n&#227;o dispon&#237;vel</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Talidomida&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Clofazimina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="8" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Chowdhry S et al&#46; Int J Mycobacteriol&#44;2016&#59;5&#40;2&#41;&#58;223&#8208;5</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="8" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Relato de caso</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="8" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">50&#160;mg&#47;semana s&#46;c&#46;<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>16&#160;semanas</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="8" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">49 anos&#44; sexo masculino</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="8" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">HV&#44; 2&#160;meses</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Prednisolona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="8" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>&#47;n&#227;o dispon&#237;vel</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Clofazimina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Talidomida&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Minociclina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Claritromicina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Ofloxacina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Pentoxifilina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Azatioprina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Santos JRS et al&#46; An Bras Dermatol&#46; 2017&#59;92&#40;4&#41;&#58;575&#8208;7</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Relato de caso</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">50&#160;mg&#47;semana s&#46;c&#46;<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>11&#160;meses</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">40 anos&#44; sexo masculino</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">HV&#44; 1&#160;ano</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Prednisolona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">N&#227;o dispon&#237;vel</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Talidomida&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="7" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Minociclina</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="7" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Narang T et al JAMA Dermatol&#46; 2015&#59;151&#40;9&#41;&#58; 1026&#8208;8</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="7" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Estudo piloto prospectivo</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="7" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">100&#160;mg&#47;dia<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>3&#160;meses</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="7" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">10 pacientes</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="7" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">8&#160;HV<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>1&#160;HBV<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>1 histoide no &#250;ltimo ano</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Prednisolona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="7" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>&#47; diminui&#231;&#227;o de 1&#160;log</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Clofazimina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Talidomida&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Pentoxifilina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Colchicina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Hidroxicloroquina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Azatioprina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Azatioprina</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Jitendra SSV et al&#46; J Clin Diagn Res&#46; 2017&#59;11&#40;8&#41;&#58;FD01&#8208;FD02</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Relato de caso</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">100&#160;mg&#47;dia<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>12&#160;meses</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">48 anos&#44; sexo masculino</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">HV&#44; 4&#160;anos</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Prednisolona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>&#47;n&#227;o dispon&#237;vel</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Clofazimina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Talidomida&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="6" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Apremilaste</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="6" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Narang T et al&#46; Br J Dermatol&#46; 2020&#59;182&#40;4&#41;&#58;1034&#8208;7</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="6" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Relato de caso</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="6" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">30&#160;mg BID 2<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>&#47;dia seguida do escalonamento da dose padr&#227;o na primeira semana<span class="elsevierStyleHsp" style=""></span>&#215;<span class="elsevierStyleHsp" style=""></span>5&#160;meses</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">34 anos&#44; sexo masculino</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">HV&#44; 8&#160;meses</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Prednisolona&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="6" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">N&#227;o dispon&#237;vel</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Clofazimina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Colchicina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">31 anos&#44; sexo masculino</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " rowspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">HV&#44; 12&#160;meses</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Minociclina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Pentoxifilina&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Talidomida&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2824199.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Lista de medicamentos experimentados no ENH recalcitrante cr&#244;nico</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Refer&#234;ncias"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:10 [
            0 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Interventions for erythema nodosum leprosum"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "N&#46;H&#46;J&#46; Veen"
                            1 => "D&#46;N&#46;J&#46; Lockwood"
                            2 => "W&#46;H&#46; Brakel"
                            3 => "J&#46; Ramirez Junior"
                            4 => "J&#46;H&#46; Richardus"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Cochrane Database Syst Rev&#46;"
                        "fecha" => "2009"
                        "volumen" => "8"
                        "paginaInicial" => "6949"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical and histopathological evaluation of the effect of addition of immunotherapy with Mw vaccine to standard chemotherapy in borderline leprosy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "R&#46; Kamal"
                            1 => "M&#46; Natrajan"
                            2 => "K&#46; Katoch"
                            3 => "M&#46; Arora"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Indian J Lepr&#46;"
                        "fecha" => "2012"
                        "volumen" => "84"
                        "paginaInicial" => "287"
                        "paginaFinal" => "306"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Epidemiological profile and severity of erythema nodosum leprosum in Brazil&#58; a cross&#8208;sectional study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "C&#46; Baima de Melo"
                            1 => "B&#46;D&#46; Silva de S&#225;"
                            2 => "F&#46;A&#46;C&#46; Costa"
                            3 => "E&#46;N&#46; Sarno"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/ijd.14895"
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Dermatol&#46;"
                        "fecha" => "2020"
                        "volumen" => "59"
                        "paginaInicial" => "856"
                        "paginaFinal" => "861"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32358972"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Current Situation of Leprosy in India and its Future Implications"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "P&#46;N&#46; Rao"
                            1 => "S&#46; Suneetha"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.4103/idoj.IDOJ_282_17"
                      "Revista" => array:6 [
                        "tituloSerie" => "Indian Dermatol Online J&#46;"
                        "fecha" => "2018"
                        "volumen" => "9"
                        "paginaInicial" => "83"
                        "paginaFinal" => "89"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29644191"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "A&#46; Polycarpou"
                            1 => "S&#46;L&#46; Walker"
                            2 => "D&#46;N&#46;J&#46; Lockwood"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3389/fimmu.2017.00233"
                      "Revista" => array:5 [
                        "tituloSerie" => "Front Immunol&#46;"
                        "fecha" => "2017"
                        "volumen" => "8"
                        "paginaInicial" => "233"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28348555"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "New Insight into the Pathogenesis of Erythema Nodosum Leprosum&#58; The Role of Activated Memory T&#8208;Cells"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "E&#46; Negera"
                            1 => "K&#46; Bobosha"
                            2 => "S&#46;L&#46; Walker"
                            3 => "B&#46; Endale"
                            4 => "R&#46; Howe"
                            5 => "A&#46; Aseffa"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.3389/fimmu.2017.01149"
                      "Revista" => array:5 [
                        "tituloSerie" => "Front Immunol&#46;"
                        "fecha" => "2017"
                        "volumen" => "8"
                        "paginaInicial" => "1149"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28966621"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Etanercept in erythema nodosum leprosum"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "J&#46;R&#46;S&#46; Santos"
                            1 => "D&#46;L&#46; Vendramini"
                            2 => "J&#46;A&#46;D&#46;C&#46; Nery"
                            3 => "J&#46;C&#46;R&#46; Avelleira"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1590/abd1806-4841.20175471"
                      "Revista" => array:6 [
                        "tituloSerie" => "An Bras Dermatol&#46;"
                        "fecha" => "2017"
                        "volumen" => "92"
                        "paginaInicial" => "575"
                        "paginaFinal" => "577"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28954119"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Apremilast in chronic recalcitrant erythema nodosum leprosum&#58; a report of two cases"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "T&#46; Narang"
                            1 => "A&#46; Kaushik"
                            2 => "S&#46; Dogra"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/bjd.18233"
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Dermatol&#46;"
                        "fecha" => "2020"
                        "volumen" => "182"
                        "paginaInicial" => "1034"
                        "paginaFinal" => "1037"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31218666"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Azathioprine in Chronic Recalcitrant Erythema Nodosum Leprosum&#58; A Case Report"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "S&#46;S&#46;V&#46; Jitendra"
                            1 => "R&#46; Bachaspatimayum"
                            2 => "A&#46;S&#46; Devi"
                            3 => "S&#46; Rita"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.7860/JCDR/2017/26536.10499"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Clin Diagn Res&#46;"
                        "fecha" => "2017"
                        "volumen" => "11"
                        "paginaInicial" => "FD01"
                        "paginaFinal" => "FD02"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28969152"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Mycobacterium indicus pranii protein MIP&#95;05962 induces Th1 cell mediated immune response in mice"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "A&#46; Sharma"
                            1 => "M&#46; Saqib"
                            2 => "J&#46;A&#46; Sheikh"
                            3 => "N&#46;Z&#46; Ehtesham"
                            4 => "S&#46; Bhaskar"
                            5 => "T&#46;K&#46; Chaudhuri"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.ijmm.2018.08.008"
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Med Microbiol&#46;"
                        "fecha" => "2018"
                        "volumen" => "308"
                        "paginaInicial" => "1000"
                        "paginaFinal" => "1008"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30190103"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "pt"
  "url" => "/26662752/0000009700000001/v1_202202030913/S2666275221002629/v1_202202030913/pt/main.assets"
  "Apartado" => array:4 [
    "identificador" => "81736"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Caso Cl&#237;nico"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/26662752/0000009700000001/v1_202202030913/S2666275221002629/v1_202202030913/pt/main.pdf?idApp=UINPBA00008Z&text.app=https://clinics.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275221002629?idApp=UINPBA00008Z"
]
Informação do artigo
ISSN: 26662752
Idioma original: Português
Dados atualizados diariamente
Ano/Mês Html Pdf Total
2024 Novembro 25 5 30
2024 Outubro 728 104 832
2024 Setembro 772 117 889
2024 Agosto 729 144 873
2024 Julho 542 121 663
2024 Junho 545 103 648
2024 Maio 342 80 422
2024 Abril 445 110 555
2024 Março 352 93 445
2024 Fevereiro 339 91 430
2024 Janeiro 364 64 428
2023 Dezembro 365 74 439
2023 Novembro 483 94 577
2023 Outubro 404 109 513
2023 Setembro 500 86 586
2023 Agosto 379 44 423
2023 Julho 343 78 421
2023 Junho 384 66 450
2023 Maio 325 24 349
2023 Abril 270 26 296
2023 Março 266 46 312
2023 Fevereiro 146 32 178
2023 Janeiro 157 67 224
2022 Dezembro 149 31 180
2022 Novembro 176 62 238
2022 Outubro 225 71 296
2022 Setembro 124 96 220
2022 Agosto 144 56 200
2022 Julho 114 72 186
2022 Junho 148 77 225
2022 Maio 153 63 216
2022 Abril 133 93 226
2022 Março 117 98 215
2022 Fevereiro 95 81 176
2022 Janeiro 70 71 141
2021 Dezembro 31 62 93
Mostrar tudo

Siga este link para acessar o texto completo do artigo

Idiomas
Anais Brasileiros de Dermatologia (Portuguese)
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.